ETIRA Trademark

Trademark Overview


On Friday, May 12, 2023, a trademark application was filed for ETIRA with the United States Patent and Trademark Office. The USPTO has given the ETIRA trademark a serial number of 97934251. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, July 24, 2025. This trademark is owned by EtiraRx Inc. The ETIRA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services
etira

General Information


Serial Number97934251
Word MarkETIRA
Filing DateFriday, May 12, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, July 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesDrug discovery services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 12, 2023
Primary Code042
First Use Anywhere DateFriday, March 31, 2023
First Use In Commerce DateSunday, April 30, 2023

Trademark Owner History


Party NameEtiraRx Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75247

Party NameEtiraRx Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75247

Trademark Events


Event DateEvent Description
Monday, June 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 16, 2023NEW APPLICATION ENTERED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024ASSIGNED TO EXAMINER
Wednesday, February 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 12, 2024USE AMENDMENT FILED
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 12, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, July 24, 2025STATEMENT OF USE PROCESSING COMPLETE

Related Keywords


etira services discovery drug